1 positions for Oncology Brand Marketing – CAR-T Professional/HCP Promotion
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, offers innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and bio-pharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships and Johnson & Johnson. Program emphasis is in Oncology Marketing. This 2-year Fellowship provides a unique opportunity to leverage their clinical expertise to evaluate the dynamic landscape of stakeholders, identify actionable insights, and generate solutions that meet customer needs. The Fellow will gain the opportunity to manage and lead projects that showcase their tactical abilities guided by the overall brand strategy.
University-based experiences include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and bio-pharmaceutical industry as future leaders. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu
Do not click the Apply Now button to the right. We do not pre-schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu
Due to the ongoing pandemic, the RPIF program will be conducting initial interviews on a rolling basis virtually (video/teleconference) from November 8th through November 19th. Candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu) to create a RPIF Candidate Account and upload the required application materialsby the dates noted below. Please see our website for additional important recruitment information and dates
Once all interviews have been completed, the company will notify candidates of their position-specific candidacy status.
Create an RPIF Candidate Account starting October 22, 2021.
Upload RPIF Application Materials to RPIF Candidate Account starting October 22, 2021.
Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Upload your Letter of Intent and Curriculum Vitae (CV) by November 1, 2021.
Begin securing letters of recommendation because all 3 must be received before you could be considered for an offer.
RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.
Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters. The following people have been designated to handle inquiries regarding the nondiscrimination policies: Judy Ryan, University wide Title IX Coordinator, Office of Enterprise Risk Management, Ethics, and Compliance (732-235-5304, firstname.lastname@example.org); and Lisa Grosskreutz, Director, Office of Employment Equity, University Human Resources (848-932-3980, email@example.com). For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or OCR.NewYork@ed.gov.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.